Five9 had a positive return on equity of 3.62% and a negative net margin of 1.23%. The business had revenue of $278.66 million for the quarter, compared to analysts’ expectations of $267.70 million.

New Custom Metrics, Analytics, and Reporting Solutions Designed to Give Businesses Faster Actionable Insights to Deliver an AI-elevated Customer Experience ENTERPRISE CONNECT – Five9 (Nasdaq ...

SAN RAMON, Calif.--(BUSINESS WIRE)--Five9, Inc. (NASDAQ:FIVN), provider of the Intelligent CX Platform, today announced that members of its management team will present at the following investor ...

Shares of NASDAQ:FIVN opened at $38.01 on Thursday. Five9 has a 52-week low of $26.60 and a 52-week high of $63.79. The stock has a market cap of $2.86 billion, a price-to-earnings ratio of -190. ...

SAN RAMON, Calif., March 13, 2025--(BUSINESS WIRE)--Five9 (Nasdaq: FIVN), provider of the Intelligent CX Platform, today released its 2025 Customer Experience Report offering insights into the ...

Majority of consumers now open to AI-powered interactions and expect GenAI to improve their experiences Five9 (Nasdaq: FIVN), provider of the Intelligent CX Platform, today released its 2025 ...

It hasn’t exactly been a smooth ride since then, but one year later Ford has finally delivered all of the complimentary NACS adapters ordered by its customers. For any company, partnering with ...

Embedded World 2025: LED design is highlighted by Rutronik with its RAB5 adapter board. It features ams Osram Osire LEDs which are designed for dynamic, ambient lighting. LEDs are customisable to meet ...

These two stocks are Five9 Inc. and Astera Labs Inc. 2 AI Stocks to Buy to Reap Benefits in the Short Term These two stocks have strong revenue and earnings potential for 2025 and have seen ...

Five9 (FIVN) closed the last trading session at $41.77, gaining 4.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...

SAN JOSE, Calif., March 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...